{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:35:37Z","timestamp":1793604937666,"version":"4.5.0"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010447","name":"Deutsches Zentrum f\u00fcr Herz-Kreislaufforschung","doi-asserted-by":"publisher","award":["81Z0710108"],"award-info":[{"award-number":["81Z0710108"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010447","name":"Deutsches Zentrum f\u00fcr Herz-Kreislaufforschung","doi-asserted-by":"publisher","award":["81Z0710108"],"award-info":[{"award-number":["81Z0710108"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e4ts-Herzzentrum Freiburg - Bad Krozingen GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiovascular diseases (CVDs) remain the leading cause of death worldwide. Most cardiovascular deaths are caused by ischaemic heart diseases such as myocardial infarction (MI). Hereby atherosclerosis in the coronary arteries often precedes disease manifestation. Since tissue remodelling plays an important role in the development and progression of atherosclerosis as well as in outcome after MI, regulation of matrix metalloproteinases (MMPs) as the major ECM-degrading enzymes with diverse other functions is crucial. Here, we provide an overview of the expression profiles of MMPs in coronary artery and left ventricular tissue using publicly available data from whole tissue to single-cell resolution. To approach an association between MMP expression and the development and outcome of CVDs, we further review studies investigating polymorphisms in MMP genes since polymorphisms are known to have an impact on gene expression. This review therefore aims to shed light on the role of MMPs in atherosclerosis and MI by summarizing current knowledge from publically available datasets, human studies, and analyses of polymorphisms up to preclinical and clinical trials of pharmacological MMP inhibition.<\/jats:p>","DOI":"10.1007\/s00395-023-00987-2","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T21:21:44Z","timestamp":1683753704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Matrix metalloproteinases in coronary artery disease and myocardial infarction"],"prefix":"10.1007","volume":"118","author":[{"given":"Hanna","family":"Br\u00e4uninger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Bacmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilian","family":"Eyerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Westermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5477-769X","authenticated-orcid":false,"given":"Diana","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"987_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084935","volume":"9","author":"A Abbas","year":"2014","unstructured":"Abbas A, Aukrust P, Russell D, Krohg-Sorensen K, Almas T, Bundgaard D, Bjerkeli V, Sagen EL, Michelsen AE, Dahl TB, Holm S, Ueland T, Skjelland M, Halvorsen B (2014) Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosis. PLoS ONE 9:e84935. https:\/\/doi.org\/10.1371\/journal.pone.0084935","journal-title":"PLoS ONE"},{"key":"987_CR2","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1161\/CIRCULATIONAHA.109.930222","volume":"122","author":"MA Ali","year":"2010","unstructured":"Ali MA, Cho WJ, Hudson B, Kassiri Z, Granzier H, Schulz R (2010) Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia\/reperfusion injury. Circulation 122:2039\u20132047. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.930222","journal-title":"Circulation"},{"key":"987_CR3","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1002\/jcp.24040","volume":"227","author":"MA Ali","year":"2012","unstructured":"Ali MA, Chow AK, Kandasamy AD, Fan X, West LJ, Crawford BD, Simmen T, Schulz R (2012) Mechanisms of cytosolic targeting of matrix metalloproteinase-2. J Cell Physiol 227:3397\u20133404. https:\/\/doi.org\/10.1002\/jcp.24040","journal-title":"J Cell Physiol"},{"key":"987_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/gtmb.2010.0113","volume":"15","author":"E Alp","year":"2011","unstructured":"Alp E, Menevse S, Tulmac M, Yilmaz A, Yalcin R, Cengel A (2011) The role of matrix metalloproteinase-2 promoter polymorphisms in coronary artery disease and myocardial infarction. Genet Test Mol Biomarkers 15:193\u2013202. https:\/\/doi.org\/10.1089\/gtmb.2010.0113","journal-title":"Genet Test Mol Biomarkers"},{"key":"987_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.kjms.2016.12.002","volume":"33","author":"E Alp","year":"2017","unstructured":"Alp E, Yilmaz A, Tulmac M, Ugras Dikmen A, Cengel A, Yalcin R, Menevse ES (2017) Analysis of MMP-7 and TIMP-2 gene polymorphisms in coronary artery disease and myocardial infarction: a Turkish case-control study. Kaohsiung J Med Sci 33:78\u201385. https:\/\/doi.org\/10.1016\/j.kjms.2016.12.002","journal-title":"Kaohsiung J Med Sci"},{"key":"987_CR6","doi-asserted-by":"publisher","first-page":"7162","DOI":"10.1111\/febs.15701","volume":"288","author":"W Bassiouni","year":"2021","unstructured":"Bassiouni W, Ali MAM, Schulz R (2021) Multifunctional intracellular matrix metalloproteinases: implications in disease. FEBS J 288:7162\u20137182. https:\/\/doi.org\/10.1111\/febs.15701","journal-title":"FEBS J"},{"key":"987_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s0021-9150(03)00149-7","volume":"169","author":"JL Beaudeux","year":"2003","unstructured":"Beaudeux JL, Giral P, Bruckert E, Bernard M, Foglietti MJ, Chapman MJ (2003) Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia. Atherosclerosis 169:139\u2013146. https:\/\/doi.org\/10.1016\/s0021-9150(03)00149-7","journal-title":"Atherosclerosis"},{"key":"987_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00395-013-0331-7","volume":"108","author":"RM Bell","year":"2013","unstructured":"Bell RM, Kunuthur SP, Hendry C, Bruce-Hickman D, Davidson S, Yellon DM (2013) Matrix metalloproteinase inhibition protects CyPD knockout mice independently of RISK\/mPTP signalling: a parallel pathway to protection. Basic Res Cardiol 108:331. https:\/\/doi.org\/10.1007\/s00395-013-0331-7","journal-title":"Basic Res Cardiol"},{"key":"987_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.phrs.2013.12.007","volume":"80","author":"P Bencsik","year":"2014","unstructured":"Bencsik P, Paloczi J, Kocsis GF, Pipis J, Belecz I, Varga ZV, Csonka C, Gorbe A, Csont T, Ferdinandy P (2014) Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective. Pharmacol Res 80:36\u201342. https:\/\/doi.org\/10.1016\/j.phrs.2013.12.007","journal-title":"Pharmacol Res"},{"key":"987_CR10","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1161\/01.Cir.0000058700.41738.12","volume":"107","author":"S Blankenberg","year":"2003","unstructured":"Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, Meyer J, Cambien F, Tiret L (2003) Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107:1579\u20131585. https:\/\/doi.org\/10.1161\/01.Cir.0000058700.41738.12","journal-title":"Circulation"},{"key":"987_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212262","author":"H Brauninger","year":"2021","unstructured":"Brauninger H, Thottakara T, Schon J, Voss S, Dhople V, Warnke S, Scherschel K, Schrage B, Kirchhof P, Blankenberg S, Volker U, Westermann D, Hammer E, Lindner D (2021) Cytokine-mediated alterations of human cardiac fibroblast\u2019s secretome. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222212262","journal-title":"Int J Mol Sci"},{"key":"987_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1161\/01.ATV.0000121571.78696.dc","volume":"24","author":"DL Brown","year":"2004","unstructured":"Brown DL, Desai KK, Vakili BA, Nouneh C, Lee HM, Golub LM (2004) Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial. Arterioscler Thromb Vasc Biol 24:733\u2013738. https:\/\/doi.org\/10.1161\/01.ATV.0000121571.78696.dc","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"987_CR13","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.healun.2003.06.005","volume":"23","author":"TM Camp","year":"2004","unstructured":"Camp TM, Tyagi SC, Aru GM, Hayden MR, Mehta JL, Tyagi SC (2004) Doxycycline ameliorates ischemic and border-zone remodeling and endothelial dysfunction after myocardial infarction in rats. J Heart Lung Transplant 23:729\u2013736. https:\/\/doi.org\/10.1016\/j.healun.2003.06.005","journal-title":"J Heart Lung Transplant"},{"key":"987_CR14","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.amjcard.2015.12.022","volume":"117","author":"E Cavusoglu","year":"2016","unstructured":"Cavusoglu E, Marmur JD, Kassotis JT, Yanamadala S, Chopra V, Eng C (2016) Usefulness of plasma matrix metalloproteinase-3 levels to predict myocardial infarction in men with and without acute coronary syndrome. Am J Cardiol 117:881\u2013886. https:\/\/doi.org\/10.1016\/j.amjcard.2015.12.022","journal-title":"Am J Cardiol"},{"key":"987_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/eurheartj\/eht420","volume":"35","author":"G Cerisano","year":"2014","unstructured":"Cerisano G, Buonamici P, Valenti R, Sciagra R, Raspanti S, Santini A, Carrabba N, Dovellini EV, Romito R, Pupi A, Colonna P, Antoniucci D (2014) Early short-term doxycycline therapy in patients with acute myocardial infarction and left ventricular dysfunction to prevent the ominous progression to adverse remodelling: the TIPTOP trial. Eur Heart J 35:184\u2013191. https:\/\/doi.org\/10.1093\/eurheartj\/eht420","journal-title":"Eur Heart J"},{"key":"987_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00395-019-0749-7","volume":"114","author":"BYH Chan","year":"2019","unstructured":"Chan BYH, Roczkowsky A, Cho WJ, Poirier M, Lee TYT, Mahmud Z, Schulz R (2019) Junctophilin-2 is a target of matrix metalloproteinase-2 in myocardial ischemia-reperfusion injury. Basic Res Cardiol 114:42. https:\/\/doi.org\/10.1007\/s00395-019-0749-7","journal-title":"Basic Res Cardiol"},{"key":"987_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/cvr\/cvaa017","volume":"117","author":"BYH Chan","year":"2021","unstructured":"Chan BYH, Roczkowsky A, Cho WJ, Poirier M, Sergi C, Keschrumrus V, Churko JM, Granzier H, Schulz R (2021) MMP inhibitors attenuate doxorubicin cardiotoxicity by preventing intracellular and extracellular matrix remodelling. Cardiovasc Res 117:188\u2013200. https:\/\/doi.org\/10.1093\/cvr\/cvaa017","journal-title":"Cardiovasc Res"},{"key":"987_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","volume":"147","author":"N Cui","year":"2017","unstructured":"Cui N, Hu M, Khalil RA (2017) Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci 147:1\u201373. https:\/\/doi.org\/10.1016\/bs.pmbts.2017.02.005","journal-title":"Prog Mol Biol Transl Sci"},{"key":"987_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/257471","volume":"2015","author":"M De Bock","year":"2015","unstructured":"De Bock M, Wang N, Decrock E, Bultynck G, Leybaert L (2015) Intracellular cleavage of the Cx43 C-terminal domain by matrix-metalloproteases: a novel contributor to inflammation? Mediators Inflamm 2015:257471. https:\/\/doi.org\/10.1155\/2015\/257471","journal-title":"Mediators Inflamm"},{"key":"987_CR20","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1089\/ars.2013.5411","volume":"21","author":"LE de Castro Bras","year":"2014","unstructured":"de Castro Bras LE, Cates CA, DeLeon-Pennell KY, Ma Y, Iyer RP, Halade GV, Yabluchanskiy A, Fields GB, Weintraub ST, Lindsey ML (2014) Citrate synthase is a novel in vivo matrix metalloproteinase-9 substrate that regulates mitochondrial function in the postmyocardial infarction left ventricle. Antioxid Redox Signal 21:1974\u20131985. https:\/\/doi.org\/10.1089\/ars.2013.5411","journal-title":"Antioxid Redox Signal"},{"key":"987_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.yjmcc.2014.09.016","volume":"77","author":"A DeCoux","year":"2014","unstructured":"DeCoux A, Lindsey ML, Villarreal F, Garcia RA, Schulz R (2014) Myocardial matrix metalloproteinase-2: inside out and upside down. J Mol Cell Cardiol 77:64\u201372. https:\/\/doi.org\/10.1016\/j.yjmcc.2014.09.016","journal-title":"J Mol Cell Cardiol"},{"key":"987_CR22","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1161\/CIRCULATIONAHA.105.562041","volume":"112","author":"JO Deguchi","year":"2005","unstructured":"Deguchi JO, Aikawa E, Libby P, Vachon JR, Inada M, Krane SM, Whittaker P, Aikawa M (2005) Matrix metalloproteinase-13\/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation 112:2708\u20132715. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.562041","journal-title":"Circulation"},{"key":"987_CR23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.yjmcc.2014.09.007","volume":"76","author":"KY DeLeon-Pennell","year":"2014","unstructured":"DeLeon-Pennell KY, de Castro Bras LE, Iyer RP, Bratton DR, Jin YF, Ripplinger CM, Lindsey ML (2014) P. gingivalis lipopolysaccharide intensifies inflammation post-myocardial infarction through matrix metalloproteinase-9. J Mol Cell Cardiol 76:218\u2013226. https:\/\/doi.org\/10.1016\/j.yjmcc.2014.09.007","journal-title":"J Mol Cell Cardiol"},{"key":"987_CR24","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1161\/CIRCRESAHA.120.316770","volume":"127","author":"MAC Depuydt","year":"2020","unstructured":"Depuydt MAC, Prange KHM, Slenders L, Ord T, Elbersen D, Boltjes A, de Jager SCA, Asselbergs FW, de Borst GJ, Aavik E, Lonnberg T, Lutgens E, Glass CK, den Ruijter HM, Kaikkonen MU, Bot I, Slutter B, van der Laan SW, Yla-Herttuala S, Mokry M, Kuiper J, de Winther MPJ, Pasterkamp G (2020) Microanatomy of the human atherosclerotic plaque by single-cell transcriptomics. Circ Res 127:1437\u20131455. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316770","journal-title":"Circ Res"},{"key":"987_CR25","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1161\/ATVBAHA.114.304088","volume":"34","author":"K Di Gregoli","year":"2014","unstructured":"Di Gregoli K, Jenkins N, Salter R, White S, Newby AC, Johnson JL (2014) MicroRNA-24 regulates macrophage behavior and retards atherosclerosis. Arterioscler Thromb Vasc Biol 34:1990\u20132000. https:\/\/doi.org\/10.1161\/ATVBAHA.114.304088","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"987_CR26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.atherosclerosis.2011.08.025","volume":"219","author":"T Djuric","year":"2011","unstructured":"Djuric T, Stankovic A, Koncar I, Radak D, Davidovic L, Alavantic D, Zivkovic M (2011) Association of MMP-8 promoter gene polymorphisms with carotid atherosclerosis: preliminary study. Atherosclerosis 219:673\u2013678. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.08.025","journal-title":"Atherosclerosis"},{"key":"987_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI8768","volume":"106","author":"A Ducharme","year":"2000","unstructured":"Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA, Werb Z, Libby P, Lee RT (2000) Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106:55\u201362. https:\/\/doi.org\/10.1172\/JCI8768","journal-title":"J Clin Invest"},{"key":"987_CR28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/jcp.21535","volume":"217","author":"A Dufour","year":"2008","unstructured":"Dufour A, Sampson NS, Zucker S, Cao J (2008) Role of the hemopexin domain of matrix metalloproteinases in cell migration. J Cell Physiol 217:643\u2013651. https:\/\/doi.org\/10.1002\/jcp.21535","journal-title":"J Cell Physiol"},{"key":"987_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071280","volume":"8","author":"M Fertin","year":"2013","unstructured":"Fertin M, Lemesle G, Turkieh A, Beseme O, Chwastyniak M, Amouyel P, Bauters C, Pinet F (2013) Serum MMP-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction. PLoS ONE 8:e71280. https:\/\/doi.org\/10.1371\/journal.pone.0071280","journal-title":"PLoS ONE"},{"key":"987_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/cells8090984","volume":"8","author":"GB Fields","year":"2019","unstructured":"Fields GB (2019) The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma. Cells 8:2. https:\/\/doi.org\/10.3390\/cells8090984","journal-title":"Cells"},{"key":"987_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/circresaha.119.311148","volume":"125","author":"NG Frangogiannis","year":"2019","unstructured":"Frangogiannis NG (2019) The extracellular matrix in ischemic and nonischemic heart failure. Circ Res 125:117\u2013146. https:\/\/doi.org\/10.1161\/circresaha.119.311148","journal-title":"Circ Res"},{"key":"987_CR32","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1002\/cphy.c150006","volume":"5","author":"NG Frangogiannis","year":"2015","unstructured":"Frangogiannis NG (2015) Pathophysiology of myocardial infarction. Compr Physiol 5:1841\u20131875. https:\/\/doi.org\/10.1002\/cphy.c150006","journal-title":"Compr Physiol"},{"key":"987_CR33","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1172\/jci117619","volume":"94","author":"ZS Galis","year":"1994","unstructured":"Galis ZS, Sukhova GK, Lark MW, Libby P (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493\u20132503. https:\/\/doi.org\/10.1172\/jci117619","journal-title":"J Clin Invest"},{"key":"987_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11010-006-9379-0","volume":"300","author":"RA Garcia","year":"2007","unstructured":"Garcia RA, Go KV, Villarreal FJ (2007) Effects of timed administration of doxycycline or methylprednisolone on post-myocardial infarction inflammation and left ventricular remodeling in the rat heart. Mol Cell Biochem 300:159\u2013169. https:\/\/doi.org\/10.1007\/s11010-006-9379-0","journal-title":"Mol Cell Biochem"},{"key":"987_CR35","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1161\/atvbaha.109.195370","volume":"30","author":"JW Gaubatz","year":"2010","unstructured":"Gaubatz JW, Ballantyne CM, Wasserman BA, He M, Chambless LE, Boerwinkle E, Hoogeveen RC (2010) Association of circulating matrix metalloproteinases with carotid artery characteristics: the Atherosclerosis Risk in Communities Carotid MRI Study. Arterioscler Thromb Vasc Biol 30:1034\u20131042. https:\/\/doi.org\/10.1161\/atvbaha.109.195370","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"987_CR36","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/s0140-6736(18)32203-7","volume":"392","author":"GBD","year":"2017","unstructured":"GBD (2017) Causes of Death Collaborators (2018) Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392:1736\u20131788. https:\/\/doi.org\/10.1016\/s0140-6736(18)32203-7","journal-title":"Lancet"},{"key":"987_CR37","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/MCA.0b013e32833ce065","volume":"21","author":"SM Ghaderian","year":"2010","unstructured":"Ghaderian SM, Akbarzadeh Najar R, Tabatabaei Panah AS (2010) Genetic polymorphisms and plasma levels of matrix metalloproteinases and their relationships with developing acute myocardial infarction. Coron Artery Dis 21:330\u2013335. https:\/\/doi.org\/10.1097\/MCA.0b013e32833ce065","journal-title":"Coron Artery Dis"},{"key":"987_CR38","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1161\/01.str.0000031929.05665.da","volume":"33","author":"G Ghilardi","year":"2002","unstructured":"Ghilardi G, Biondi ML, DeMonti M, Turri O, Guagnellini E, Scorza R (2002) Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke 33:2408\u20132412. https:\/\/doi.org\/10.1161\/01.str.0000031929.05665.da","journal-title":"Stroke"},{"key":"987_CR39","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"GTEx Consortium","year":"2020","unstructured":"GTEx Consortium (2020) The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369:1318\u20131330. https:\/\/doi.org\/10.1126\/science.aaz1776","journal-title":"Science"},{"key":"987_CR40","doi-asserted-by":"publisher","first-page":"9748","DOI":"10.1073\/pnas.93.18.9748","volume":"93","author":"I Halpert","year":"1996","unstructured":"Halpert I, Sires UI, Roby JD, Potter-Perigo S, Wight TN, Shapiro SD, Welgus HG, Wickline SA, Parks WC (1996) Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci U S A 93:9748\u20139753. https:\/\/doi.org\/10.1073\/pnas.93.18.9748","journal-title":"Proc Natl Acad Sci U S A"},{"key":"987_CR41","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/eurheartj\/ehaa035","volume":"41","author":"TS Hartikainen","year":"2020","unstructured":"Hartikainen TS, S\u00f6rensen NA, Haller PM, Go\u00dfling A, Lehmacher J, Zeller T, Blankenberg S, Westermann D, Neumann JT (2020) Clinical application of the 4th universal definition of myocardial infarction. Eur Heart J 41:2209\u20132216. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa035","journal-title":"Eur Heart J"},{"key":"987_CR42","doi-asserted-by":"publisher","first-page":"H1229","DOI":"10.1152\/ajpheart.00207.2003","volume":"285","author":"S Hayashidani","year":"2003","unstructured":"Hayashidani S, Tsutsui H, Ikeuchi M, Shiomi T, Matsusaka H, Kubota T, Imanaka-Yoshida K, Itoh T, Takeshita A (2003) Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am J Physiol Heart Circ Physiol 285:H1229-1235. https:\/\/doi.org\/10.1152\/ajpheart.00207.2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"987_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3988\/jcn.2011.7.2.69","volume":"7","author":"SH Heo","year":"2011","unstructured":"Heo SH, Cho CH, Kim HO, Jo YH, Yoon KS, Lee JH, Park JC, Park KC, Ahn TB, Chung KC, Yoon SS, Chang DI (2011) Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9. J Clin Neurol 7:69\u201376. https:\/\/doi.org\/10.3988\/jcn.2011.7.2.69","journal-title":"J Clin Neurol"},{"key":"987_CR44","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/S0140-6736(14)60107-0","volume":"383","author":"G Heusch","year":"2014","unstructured":"Heusch G, Libby P, Gersh B, Yellon D, Bohm M, Lopaschuk G, Opie L (2014) Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 383:1933\u20131943. https:\/\/doi.org\/10.1016\/S0140-6736(14)60107-0","journal-title":"Lancet"},{"key":"987_CR45","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/13459","volume":"5","author":"S Heymans","year":"1999","unstructured":"Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A, Levi M, Nube O, Baker A, Keshet E, Lupu F, Herbert JM, Smits JF, Shapiro SD, Baes M, Borgers M, Collen D, Daemen MJ, Carmeliet P (1999) Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5:1135\u20131142. https:\/\/doi.org\/10.1038\/13459","journal-title":"Nat Med"},{"key":"987_CR46","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ahj.2007.06.030","volume":"154","author":"BD Horne","year":"2007","unstructured":"Horne BD, Camp NJ, Carlquist JF, Muhlestein JB, Kolek MJ, Nicholas ZP, Anderson JL (2007) Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease. Am Heart J 154:751\u2013758. https:\/\/doi.org\/10.1016\/j.ahj.2007.06.030","journal-title":"Am Heart J"},{"key":"987_CR47","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.3892\/etm.2017.5623","volume":"15","author":"W Hu","year":"2018","unstructured":"Hu W, Wei R, Wang L, Lu J, Liu H, Zhang W (2018) Correlations of MMP-1, MMP-3, and MMP-12 with the degree of atherosclerosis, plaque stability and cardiovascular and cerebrovascular events. Exp Ther Med 15:1994\u20131998. https:\/\/doi.org\/10.3892\/etm.2017.5623","journal-title":"Exp Ther Med"},{"key":"987_CR48","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1515\/cclm.2011.241","volume":"49","author":"XF Hu","year":"2011","unstructured":"Hu XF, Jin XP, Hu PY, Zhu M, Wang F, Lin XF, Li WL, Ni H, Yang LH (2011) Association of a functional polymorphism in the MMP7 gene promoter with susceptibility to vulnerable carotid plaque in a Han Chinese population. Clin Chem Lab Med 49:1735\u20131741. https:\/\/doi.org\/10.1515\/cclm.2011.241","journal-title":"Clin Chem Lab Med"},{"key":"987_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jacc.2006.02.055","volume":"48","author":"MP Hudson","year":"2006","unstructured":"Hudson MP, Armstrong PW, Ruzyllo W, Brum J, Cusmano L, Krzeski P, Lyon R, Quinones M, Theroux P, Sydlowski D, Kim HE, Garcia MJ, Jaber WA, Weaver WD (2006) Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (prevention of myocardial infarction early remodeling) trial. J Am Coll Cardiol 48:15\u201320. https:\/\/doi.org\/10.1016\/j.jacc.2006.02.055","journal-title":"J Am Coll Cardiol"},{"key":"987_CR50","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s00395-014-0424-y","volume":"109","author":"BG Hughes","year":"2014","unstructured":"Hughes BG, Schulz R (2014) Targeting MMP-2 to treat ischemic heart injury. Basic Res Cardiol 109:424. https:\/\/doi.org\/10.1007\/s00395-014-0424-y","journal-title":"Basic Res Cardiol"},{"key":"987_CR51","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s0021-9150(98)00053-7","volume":"139","author":"SE Humphries","year":"1998","unstructured":"Humphries SE, Luong LA, Talmud PJ, Frick MH, Kesaniemi YA, Pasternack A, Taskinen MR, Syvanne M (1998) The 5A\/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial. Atherosclerosis 139:49\u201356. https:\/\/doi.org\/10.1016\/s0021-9150(98)00053-7","journal-title":"Atherosclerosis"},{"key":"987_CR52","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.yjmcc.2016.10.005","volume":"100","author":"RP Iyer","year":"2016","unstructured":"Iyer RP, de Castro Bras LE, Patterson NL, Bhowmick M, Flynn ER, Asher M, Cannon PL, Deleon-Pennell KY, Fields GB, Lindsey ML (2016) Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution. J Mol Cell Cardiol 100:109\u2013117. https:\/\/doi.org\/10.1016\/j.yjmcc.2016.10.005","journal-title":"J Mol Cell Cardiol"},{"key":"987_CR53","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijcard.2015.03.054","volume":"185","author":"RP Iyer","year":"2015","unstructured":"Iyer RP, Patterson NL, Zouein FA, Ma Y, Dive V, de Castro Bras LE, Lindsey ML (2015) Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution. Int J Cardiol 185:198\u2013208. https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.054","journal-title":"Int J Cardiol"},{"key":"987_CR54","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/1479-7364-4-3-194","volume":"4","author":"BC Jackson","year":"2010","unstructured":"Jackson BC, Nebert DW, Vasiliou V (2010) Update of human and mouse matrix metalloproteinase families. Hum Genom 4:194\u2013201. https:\/\/doi.org\/10.1186\/1479-7364-4-3-194","journal-title":"Hum Genom"},{"key":"987_CR55","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.atherosclerosis.2009.08.018","volume":"208","author":"BJ Jefferis","year":"2010","unstructured":"Jefferis BJ, Whincup P, Welsh P, Wannamethee G, Rumley A, Lennon L, Thomson A, Lawlor D, Carson C, Ebrahim S, Lowe G (2010) Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women. Atherosclerosis 208:557\u2013563. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.08.018","journal-title":"Atherosclerosis"},{"key":"987_CR56","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.bbamcr.2017.05.013","volume":"1864","author":"PG Jobin","year":"2017","unstructured":"Jobin PG, Butler GS, Overall CM (2017) New intracellular activities of matrix metalloproteinases shine in the moonlight. Biochim Biophys Acta Mol Cell Res 1864:2043\u20132055. https:\/\/doi.org\/10.1016\/j.bbamcr.2017.05.013","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"987_CR57","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1161\/ATVBAHA.110.219147","volume":"31","author":"JL Johnson","year":"2011","unstructured":"Johnson JL, Devel L, Czarny B, George SJ, Jackson CL, Rogakos V, Beau F, Yiotakis A, Newby AC, Dive V (2011) A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice. Arterioscler Thromb Vasc Biol 31:528\u2013535. https:\/\/doi.org\/10.1161\/ATVBAHA.110.219147","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"987_CR58","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.cardiores.2006.05.009","volume":"71","author":"JL Johnson","year":"2006","unstructured":"Johnson JL, Fritsche-Danielson R, Behrendt M, Westin-Eriksson A, Wennbo H, Herslof M, Elebring M, George SJ, McPheat WL, Jackson CL (2006) Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability. Cardiovasc Res 71:586\u2013595. https:\/\/doi.org\/10.1016\/j.cardiores.2006.05.009","journal-title":"Cardiovasc Res"},{"key":"987_CR59","doi-asserted-by":"publisher","first-page":"15575","DOI":"10.1073\/pnas.0506201102","volume":"102","author":"JL Johnson","year":"2005","unstructured":"Johnson JL, George SJ, Newby AC, Jackson CL (2005) Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc Natl Acad Sci U S A 102:15575\u201315580. https:\/\/doi.org\/10.1073\/pnas.0506201102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"987_CR60","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1161\/hq1101.098229","volume":"21","author":"S Jormsjo","year":"2001","unstructured":"Jormsjo S, Whatling C, Walter DH, Zeiher AM, Hamsten A, Eriksson P (2001) Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 21:1834\u20131839. https:\/\/doi.org\/10.1161\/hq1101.098229","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"987_CR61","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/cvr\/cvp175","volume":"83","author":"AD Kandasamy","year":"2009","unstructured":"Kandasamy AD, Schulz R (2009) Glycogen synthase kinase-3beta is activated by matrix metalloproteinase-2 mediated proteolysis in cardiomyoblasts. Cardiovasc Res 83:698\u2013706. https:\/\/doi.org\/10.1093\/cvr\/cvp175","journal-title":"Cardiovasc Res"},{"key":"987_CR62","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/eurheartj\/ehm003","volume":"28","author":"D Kelly","year":"2007","unstructured":"Kelly D, Cockerill G, Ng LL, Thompson M, Khan S, Samani NJ, Squire IB (2007) Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study. Eur Heart J 28:711\u2013718. https:\/\/doi.org\/10.1093\/eurheartj\/ehm003","journal-title":"Eur Heart J"},{"key":"987_CR63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejheart.2007.12.009","volume":"10","author":"D Kelly","year":"2008","unstructured":"Kelly D, Khan S, Cockerill G, Ng LL, Thompson M, Samani NJ, Squire IB (2008) Circulating stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction. Eur J Heart Fail 10:133\u2013139. https:\/\/doi.org\/10.1016\/j.ejheart.2007.12.009","journal-title":"Eur J Heart Fail"},{"key":"987_CR64","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.atherosclerosis.2009.08.021","volume":"208","author":"W Koch","year":"2010","unstructured":"Koch W, de Waha A, Hoppmann P, Schomig A, Kastrati A (2010) Haplotypes and 5A\/6A polymorphism of the matrix metalloproteinase-3 gene in coronary disease: case\u2013control study and a meta-analysis. Atherosclerosis 208:171\u2013176. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.08.021","journal-title":"Atherosclerosis"},{"key":"987_CR65","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.yjmcc.2019.04.007","volume":"131","author":"A Kubota","year":"2019","unstructured":"Kubota A, Suto A, Suzuki K, Kobayashi Y, Nakajima H (2019) Matrix metalloproteinase-12 produced by Ly6C(low) macrophages prolongs the survival after myocardial infarction by preventing neutrophil influx. J Mol Cell Cardiol 131:41\u201352. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.04.007","journal-title":"J Mol Cell Cardiol"},{"key":"987_CR66","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41586-022-05060-x","volume":"608","author":"C Kuppe","year":"2022","unstructured":"Kuppe C, Ramirez Flores RO, Li Z, Hayat S, Levinson RT, Liao X, Hannani MT, Tanevski J, Wunnemann F, Nagai JS, Halder M, Schumacher D, Menzel S, Schafer G, Hoeft K, Cheng M, Ziegler S, Zhang X, Peisker F, Kaesler N, Saritas T, Xu Y, Kassner A, Gummert J, Morshuis M, Amrute J, Veltrop RJA, Boor P, Klingel K, Van Laake LW, Vink A, Hoogenboezem RM, Bindels EMJ, Schurgers L, Sattler S, Schapiro D, Schneider RK, Lavine K, Milting H, Costa IG, Saez-Rodriguez J, Kramann R (2022) Spatial multi-omic map of human myocardial infarction. Nature 608:766\u2013777. https:\/\/doi.org\/10.1038\/s41586-022-05060-x","journal-title":"Nature"},{"key":"987_CR67","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1161\/01.ATV.0000218496.60097.e0","volume":"26","author":"M Kuzuya","year":"2006","unstructured":"Kuzuya M, Nakamura K, Sasaki T, Cheng XW, Itohara S, Iguchi A (2006) Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice. Arterioscler Thromb Vasc Biol 26:1120\u20131125. https:\/\/doi.org\/10.1161\/01.ATV.0000218496.60097.e0","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"987_CR68","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1161\/CIRCRESAHA.109.200279","volume":"105","author":"RC Laxton","year":"2009","unstructured":"Laxton RC, Hu Y, Duchene J, Zhang F, Zhang Z, Leung KY, Xiao Q, Scotland RS, Hodgkinson CP, Smith K, Willeit J, Lopez-Otin C, Simpson IA, Kiechl S, Ahluwalia A, Xu Q, Ye S (2009) A role of matrix metalloproteinase-8 in atherosclerosis. Circ Res 105:921\u2013929. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.200279","journal-title":"Circ Res"},{"key":"987_CR69","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1475-2840-8-50","volume":"8","author":"M Lehrke","year":"2009","unstructured":"Lehrke M, Greif M, Broedl UC, Lebherz C, Laubender RP, Becker A, von Ziegler F, Tittus J, Reiser M, Becker C, Goke B, Steinbeck G, Leber AW, Parhofer KG (2009) MMP-1 serum levels predict coronary atherosclerosis in humans. Cardiovasc Diabetol 8:50. https:\/\/doi.org\/10.1186\/1475-2840-8-50","journal-title":"Cardiovasc Diabetol"},{"key":"987_CR70","doi-asserted-by":"publisher","first-page":"1040171","DOI":"10.1155\/2021\/1040171","volume":"2021","author":"Y Li","year":"2021","unstructured":"Li Y, Li L, Wang K, Wu P, Cui Y (2021) Investigation on risk stratification and the prognostic value of hs-TnT combined with MMP-2 in patients with acute coronary syndrome. Biomed Res Int 2021:1040171. https:\/\/doi.org\/10.1155\/2021\/1040171","journal-title":"Biomed Res Int"},{"key":"987_CR71","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/875742","volume":"2012","author":"D Lindner","year":"2012","unstructured":"Lindner D, Zietsch C, Becher PM, Schulze K, Schultheiss HP, Tschope C, Westermann D (2012) Differential expression of matrix metalloproteases in human fibroblasts with different origins. Biochem Res Int 2012:875742. https:\/\/doi.org\/10.1155\/2012\/875742","journal-title":"Biochem Res Int"},{"key":"987_CR72","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1161\/CIRCULATIONAHA.106.612960","volume":"113","author":"ML Lindsey","year":"2006","unstructured":"Lindsey ML, Escobar GP, Mukherjee R, Goshorn DK, Sheats NJ, Bruce JA, Mains IM, Hendrick JK, Hewett KW, Gourdie RG, Matrisian LM, Spinale FG (2006) Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation 113:2919\u20132928. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.612960","journal-title":"Circulation"},{"key":"987_CR73","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1161\/hc0602.103674","volume":"105","author":"ML Lindsey","year":"2002","unstructured":"Lindsey ML, Gannon J, Aikawa M, Schoen FJ, Rabkin E, Lopresti-Morrow L, Crawford J, Black S, Libby P, Mitchell PG, Lee RT (2002) Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction. Circulation 105:753\u2013758. https:\/\/doi.org\/10.1161\/hc0602.103674","journal-title":"Circulation"},{"key":"987_CR74","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","volume":"588","author":"M Litvinukova","year":"2020","unstructured":"Litvinukova M, Talavera-Lopez C, Maatz H, Reichart D, Worth CL, Lindberg EL, Kanda M, Polanski K, Heinig M, Lee M, Nadelmann ER, Roberts K, Tuck L, Fasouli ES, DeLaughter DM, McDonough B, Wakimoto H, Gorham JM, Samari S, Mahbubani KT, Saeb-Parsy K, Patone G, Boyle JJ, Zhang H, Zhang H, Viveiros A, Oudit GY, Bayraktar OA, Seidman JG, Seidman CE, Noseda M, Hubner N, Teichmann SA (2020) Cells of the adult human heart. Nature 588:466\u2013472. https:\/\/doi.org\/10.1038\/s41586-020-2797-4","journal-title":"Nature"},{"key":"987_CR75","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1161\/01.str.31.1.40","volume":"31","author":"IM Loftus","year":"2000","unstructured":"Loftus IM, Naylor AR, Goodall S, Crowther M, Jones L, Bell PR, Thompson MM (2000) Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke 31:40\u201347. https:\/\/doi.org\/10.1161\/01.str.31.1.40","journal-title":"Stroke"},{"key":"987_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034177","volume":"7","author":"DH Lovett","year":"2012","unstructured":"Lovett DH, Mahimkar R, Raffai RL, Cape L, Maklashina E, Cecchini G, Karliner JS (2012) A novel intracellular isoform of matrix metalloproteinase-2 induced by oxidative stress activates innate immunity. PLoS ONE 7:e34177. https:\/\/doi.org\/10.1371\/journal.pone.0034177","journal-title":"PLoS ONE"},{"key":"987_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068154","volume":"8","author":"DH Lovett","year":"2013","unstructured":"Lovett DH, Mahimkar R, Raffai RL, Cape L, Zhu BQ, Jin ZQ, Baker AJ, Karliner JS (2013) N-terminal truncated intracellular matrix metalloproteinase-2 induces cardiomyocyte hypertrophy, inflammation and systolic heart failure. PLoS ONE 8:e68154. https:\/\/doi.org\/10.1371\/journal.pone.0068154","journal-title":"PLoS ONE"},{"key":"987_CR78","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1161\/01.CIR.0000121728.14930.DE","volume":"109","author":"A Luttun","year":"2004","unstructured":"Luttun A, Lutgens E, Manderveld A, Maris K, Collen D, Carmeliet P, Moons L (2004) Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation 109:1408\u20131414. https:\/\/doi.org\/10.1161\/01.CIR.0000121728.14930.DE","journal-title":"Circulation"},{"key":"987_CR79","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1161\/CIRCRESAHA.111.300502","volume":"112","author":"Y Ma","year":"2013","unstructured":"Ma Y, Halade GV, Zhang J, Ramirez TA, Levin D, Voorhees A, Jin YF, Han HC, Manicone AM, Lindsey ML (2013) Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation. Circ Res 112:675\u2013688. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.300502","journal-title":"Circ Res"},{"key":"987_CR80","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/joim.12655","volume":"282","author":"H Mahdessian","year":"2017","unstructured":"Mahdessian H, Perisic Matic L, Lengquist M, Gertow K, Sennblad B, Baldassarre D, Veglia F, Humphries SE, Rauramaa R, de Faire U, Smit AJ, Giral P, Kurl S, Mannarino E, Tremoli E, Hamsten A, Eriksson P, Hedin U, Malarstig A (2017) Integrative studies implicate matrix metalloproteinase-12 as a culprit gene for large-artery atherosclerotic stroke. J Intern Med 282:429\u2013444. https:\/\/doi.org\/10.1111\/joim.12655","journal-title":"J Intern Med"},{"key":"987_CR81","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1161\/01.ATV.0000058404.92759.32","volume":"23","author":"MW Manning","year":"2003","unstructured":"Manning MW, Cassis LA, Daugherty A (2003) Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 23:483\u2013488. https:\/\/doi.org\/10.1161\/01.ATV.0000058404.92759.32","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"987_CR82","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.amjcard.2004.06.064","volume":"94","author":"TN Martin","year":"2004","unstructured":"Martin TN, Penney DE, Smith JA, Groenning BA, Dargie HJ, Hillis GS (2004) Matrix metalloproteinase-1 promoter polymorphisms and changes in left ventricular volume following acute myocardial infarction. Am J Cardiol 94:1044\u20131046. https:\/\/doi.org\/10.1016\/j.amjcard.2004.06.064","journal-title":"Am J Cardiol"},{"key":"987_CR83","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1172\/jci22304","volume":"115","author":"S Matsumura","year":"2005","unstructured":"Matsumura S, Iwanaga S, Mochizuki S, Okamoto H, Ogawa S, Okada Y (2005) Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J Clin Invest 115:599\u2013609. https:\/\/doi.org\/10.1172\/jci22304","journal-title":"J Clin Invest"},{"key":"987_CR84","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ijcard.2005.01.011","volume":"105","author":"T Matsunaga","year":"2005","unstructured":"Matsunaga T, Abe N, Kameda K, Hagii J, Fujita N, Onodera H, Kamata T, Ishizaka H, Hanada H, Osanai T, Okumura K (2005) Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction. Int J Cardiol 105:203\u2013208. https:\/\/doi.org\/10.1016\/j.ijcard.2005.01.011","journal-title":"Int J Cardiol"},{"key":"987_CR85","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ehj.2004.01.015","volume":"25","author":"F Mizon-Gerard","year":"2004","unstructured":"Mizon-Gerard F, de Groote P, Lamblin N, Hermant X, Dallongeville J, Amouyel P, Bauters C, Helbecque N (2004) Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunction. Eur Heart J 25:688\u2013693. https:\/\/doi.org\/10.1016\/j.ehj.2004.01.015","journal-title":"Eur Heart J"},{"key":"987_CR86","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/01.Cir.0000135588.65188.14","volume":"110","author":"KJ Molloy","year":"2004","unstructured":"Molloy KJ, Thompson MM, Jones JL, Schwalbe EC, Bell PR, Naylor AR, Loftus IM (2004) Unstable carotid plaques exhibit raised matrix metalloproteinase-8 activity. Circulation 110:337\u2013343. https:\/\/doi.org\/10.1161\/01.Cir.0000135588.65188.14","journal-title":"Circulation"},{"key":"987_CR87","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jacc.2005.10.070","volume":"47","author":"I Montero","year":"2006","unstructured":"Montero I, Orbe J, Varo N, Beloqui O, Monreal JI, Rodriguez JA, Diez J, Libby P, Paramo JA (2006) C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol 47:1369\u20131378. https:\/\/doi.org\/10.1016\/j.jacc.2005.10.070","journal-title":"J Am Coll Cardiol"},{"key":"987_CR88","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00109-003-0441-z","volume":"81","author":"AR Morgan","year":"2003","unstructured":"Morgan AR, Zhang B, Tapper W, Collins A, Ye S (2003) Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease. J Mol Med 81:321\u2013326. https:\/\/doi.org\/10.1007\/s00109-003-0441-z","journal-title":"J Mol Med"},{"key":"987_CR89","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1161\/01.cir.0000046449.36178.00","volume":"107","author":"R Mukherjee","year":"2003","unstructured":"Mukherjee R, Brinsa TA, Dowdy KB, Scott AA, Baskin JM, Deschamps AM, Lowry AS, Escobar GP, Lucas DG, Yarbrough WM, Zile MR, Spinale FG (2003) Myocardial infarct expansion and matrix metalloproteinase inhibition. Circulation 107:618\u2013625. https:\/\/doi.org\/10.1161\/01.cir.0000046449.36178.00","journal-title":"Circulation"},{"key":"987_CR90","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","volume":"69","author":"H Nagase","year":"2006","unstructured":"Nagase H, Visse R, Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69:562\u2013573. https:\/\/doi.org\/10.1016\/j.cardiores.2005.12.002","journal-title":"Cardiovasc Res"},{"key":"987_CR91","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/heartjnl-2011-300079","volume":"98","author":"L Nilsson","year":"2012","unstructured":"Nilsson L, Hallen J, Atar D, Jonasson L, Swahn E (2012) Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction. Heart 98:31\u201336. https:\/\/doi.org\/10.1136\/heartjnl-2011-300079","journal-title":"Heart"},{"key":"987_CR92","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cjca.2013.11.014","volume":"30","author":"V Olsen","year":"2014","unstructured":"Olsen V, Rohde LE, Beck-da-Silva L, Santos KG, Biolo A, Clausell N, Andrades M (2014) QRS widening rates and genetic polymorphisms of matrix metalloproteinases in a cohort of patients with chronic heart failure. Can J Cardiol 30:345\u2013351. https:\/\/doi.org\/10.1016\/j.cjca.2013.11.014","journal-title":"Can J Cardiol"},{"key":"987_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106816","volume":"9","author":"TB Opstad","year":"2014","unstructured":"Opstad TB, Arnesen H, Pettersen AA, Seljeflot I (2014) The MMP-9 -1562 C\/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease. PLoS ONE 9:e106816. https:\/\/doi.org\/10.1371\/journal.pone.0106816","journal-title":"PLoS ONE"},{"key":"987_CR94","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1538-7836.2006.02276.x","volume":"5","author":"J Orbe","year":"2007","unstructured":"Orbe J, Montero I, Rodriguez JA, Beloqui O, Roncal C, Paramo JA (2007) Independent association of matrix metalloproteinase-10, cardiovascular risk factors and subclinical atherosclerosis. J Thromb Haemost 5:91\u201397. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02276.x","journal-title":"J Thromb Haemost"},{"key":"987_CR95","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11239-019-02004-7","volume":"49","author":"US Owolabi","year":"2020","unstructured":"Owolabi US, Amraotkar AR, Coulter AR, Singam NSV, Aladili BN, Singh A, Trainor PJ, Mitra R, DeFilippis AP (2020) Change in matrix metalloproteinase 2, 3, and 9 levels at the time of and after acute atherothrombotic myocardial infarction. J Thromb Thrombolysis 49:235\u2013244. https:\/\/doi.org\/10.1007\/s11239-019-02004-7","journal-title":"J Thromb Thrombolysis"},{"key":"987_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2015.11.083","volume":"77","author":"C Palombo","year":"2016","unstructured":"Palombo C, Kozakova M (2016) Arterial stiffness, atherosclerosis and cardiovascular risk: Pathophysiologic mechanisms and emerging clinical indications. Vascul Pharmacol 77:1\u20137. https:\/\/doi.org\/10.1016\/j.vph.2015.11.083","journal-title":"Vascul Pharmacol"},{"key":"987_CR97","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1177\/1358863x13502698","volume":"18","author":"AG Panayiotou","year":"2013","unstructured":"Panayiotou AG, Griffin MB, Tyllis T, Georgiou N, Bond D, Humphries SE, Nicolaides AN (2013) Association of genotypes at the matrix metalloproteinase (MMP) loci with carotid IMT and presence of carotid and femoral atherosclerotic plaques. Vasc Med 18:298\u2013306. https:\/\/doi.org\/10.1177\/1358863x13502698","journal-title":"Vasc Med"},{"key":"987_CR98","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s13353-016-0388-8","volume":"58","author":"M Pavkova Goldbergova","year":"2017","unstructured":"Pavkova Goldbergova M, Jarkovsky J, Lipkova J, Littnerova S, Poloczek M, Spinar J, Kubkova L, Kluz K, Kala P, Manousek J, Vasku A, Parenica J (2017) Relationship of long-term prognosis to MMP and TIMP polymorphisms in patients after ST elevation myocardial infarction. J Appl Genet 58:331\u2013341. https:\/\/doi.org\/10.1007\/s13353-016-0388-8","journal-title":"J Appl Genet"},{"key":"987_CR99","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1093\/eurheartj\/ehq517","volume":"32","author":"W Peeters","year":"2011","unstructured":"Peeters W, Moll FL, Vink A, van der Spek PJ, de Kleijn DP, de Vries JP, Verheijen JH, Newby AC, Pasterkamp G (2011) Collagenase matrix metalloproteinase-8 expressed in atherosclerotic carotid plaques is associated with systemic cardiovascular outcome. Eur Heart J 32:2314\u20132325. https:\/\/doi.org\/10.1093\/eurheartj\/ehq517","journal-title":"Eur Heart J"},{"key":"987_CR100","doi-asserted-by":"publisher","first-page":"718","DOI":"10.5551\/jat.11817","volume":"19","author":"N Perez-Hernandez","year":"2012","unstructured":"Perez-Hernandez N, Vargas-Alarcon G, Martinez-Rodriguez N, Martinez-Rios MA, Pena-Duque MA, Pena-Diaz Ade L, Valente-Acosta B, Posadas-Romero C, Medina A, Rodriguez-Perez JM (2012) The matrix metalloproteinase 2\u20131575 gene polymorphism is associated with the risk of developing myocardial infarction in Mexican patients. J Atheroscler Thromb 19:718\u2013727. https:\/\/doi.org\/10.5551\/jat.11817","journal-title":"J Atheroscler Thromb"},{"key":"987_CR101","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1161\/hq0901.095545","volume":"21","author":"PJ Pollanen","year":"2001","unstructured":"Pollanen PJ, Karhunen PJ, Mikkelsson J, Laippala P, Perola M, Penttila A, Mattila KM, Koivula T, Lehtimaki T (2001) Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: an autopsy study. Arterioscler Thromb Vasc Biol 21:1446\u20131450. https:\/\/doi.org\/10.1161\/hq0901.095545","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"987_CR102","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1749-6632.1999.tb07683.x","volume":"878","author":"MF Prescott","year":"1999","unstructured":"Prescott MF, Sawyer WK, Von Linden-Reed J, Jeune M, Chou M, Caplan SL, Jeng AY (1999) Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury. Ann N Y Acad Sci 878:179\u2013190. https:\/\/doi.org\/10.1111\/j.1749-6632.1999.tb07683.x","journal-title":"Ann N Y Acad Sci"},{"key":"987_CR103","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP (2011) Integrative genomics viewer. Nat Biotechnol 29:24\u201326. https:\/\/doi.org\/10.1038\/nbt.1754","journal-title":"Nat Biotechnol"},{"key":"987_CR104","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/cvr\/cvz207","volume":"116","author":"A Roczkowsky","year":"2020","unstructured":"Roczkowsky A, Chan BYH, Lee TYT, Mahmud Z, Hartley B, Julien O, Armanious G, Young HS, Schulz R (2020) Myocardial MMP-2 contributes to SERCA2a proteolysis during cardiac ischaemia-reperfusion injury. Cardiovasc Res 116:1021\u20131031. https:\/\/doi.org\/10.1093\/cvr\/cvz207","journal-title":"Cardiovasc Res"},{"key":"987_CR105","doi-asserted-by":"publisher","first-page":"15017776","DOI":"10.4238\/gmr.15017776","volume":"15","author":"JM Rodriguez-Perez","year":"2016","unstructured":"Rodriguez-Perez JM, Vargas-Alarcon G, Posadas-Sanchez R, Zagal-Jimenez TX, Ortiz-Alarcon R, Valente-Acosta B, Tovilla-Zarate C, Nostroza-Hernandez C, Perez-Mendez O, Perez-Hernandez N (2016) rs3918242 MMP9 gene polymorphism is associated with myocardial infarction in Mexican patients. Genet Mol Res 15:15017776. https:\/\/doi.org\/10.4238\/gmr.15017776","journal-title":"Genet Mol Res"},{"key":"987_CR106","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1161\/01.cir.99.23.3063","volume":"99","author":"LE Rohde","year":"1999","unstructured":"Rohde LE, Ducharme A, Arroyo LH, Aikawa M, Sukhova GH, Lopez-Anaya A, McClure KF, Mitchell PG, Libby P, Lee RT (1999) Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 99:3063\u20133070. https:\/\/doi.org\/10.1161\/01.cir.99.23.3063","journal-title":"Circulation"},{"key":"987_CR107","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/s1388-9842(99)00048-3","volume":"1","author":"P Rouet-Benzineb","year":"1999","unstructured":"Rouet-Benzineb P, Buhler JM, Dreyfus P, Delcourt A, Dorent R, Perennec J, Crozatier B, Harf A, Lafuma C (1999) Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation. Eur J Heart Fail 1:337\u2013352. https:\/\/doi.org\/10.1016\/s1388-9842(99)00048-3","journal-title":"Eur J Heart Fail"},{"key":"987_CR108","first-page":"5321","volume":"58","author":"JL Rutter","year":"1998","unstructured":"Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ, Brinckerhoff CE (1998) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58:5321\u20135325","journal-title":"Cancer Res"},{"key":"987_CR109","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.104.531616","volume":"112","author":"G Sawicki","year":"2005","unstructured":"Sawicki G, Leon H, Sawicka J, Sariahmetoglu M, Schulze CJ, Scott PG, Szczesna-Cordary D, Schulz R (2005) Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation 112:544\u2013552. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.531616","journal-title":"Circulation"},{"key":"987_CR110","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1155\/2002\/418383","volume":"18","author":"A Schwarz","year":"2002","unstructured":"Schwarz A, Haberbosch W, Tillmanns H, Gardemann A (2002) The stromelysin-1 5A\/6A promoter polymorphism is a disease marker for the extent of coronary heart disease. Dis Markers 18:121\u2013128. https:\/\/doi.org\/10.1155\/2002\/418383","journal-title":"Dis Markers"},{"key":"987_CR111","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1161\/01.STR.0000196986.50059.e0","volume":"37","author":"JP Sluijter","year":"2006","unstructured":"Sluijter JP, Pulskens WP, Schoneveld AH, Velema E, Strijder CF, Moll F, de Vries JP, Verheijen J, Hanemaaijer R, de Kleijn DP, Pasterkamp G (2006) Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms. Stroke 37:235\u2013239. https:\/\/doi.org\/10.1161\/01.STR.0000196986.50059.e0","journal-title":"Stroke"},{"key":"987_CR112","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.cardfail.2003.11.003","volume":"10","author":"IB Squire","year":"2004","unstructured":"Squire IB, Evans J, Ng LL, Loftus IM, Thompson MM (2004) Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction. J Card Fail 10:328\u2013333. https:\/\/doi.org\/10.1016\/j.cardfail.2003.11.003","journal-title":"J Card Fail"},{"key":"987_CR113","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1161\/01.cir.99.19.2503","volume":"99","author":"GK Sukhova","year":"1999","unstructured":"Sukhova GK, Schonbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, Libby P (1999) Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 99:2503\u20132509. https:\/\/doi.org\/10.1161\/01.cir.99.19.2503","journal-title":"Circulation"},{"key":"987_CR114","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.yjmcc.2007.07.055","volume":"43","author":"MM Sung","year":"2007","unstructured":"Sung MM, Schulz CG, Wang W, Sawicki G, Bautista-Lopez NL, Schulz R (2007) Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury. J Mol Cell Cardiol 43:429\u2013436. https:\/\/doi.org\/10.1016\/j.yjmcc.2007.07.055","journal-title":"J Mol Cell Cardiol"},{"key":"987_CR115","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bbamcr.2009.04.003","volume":"1803","author":"C Tallant","year":"2010","unstructured":"Tallant C, Marrero A, Gomis-R\u00fcth FX (2010) Matrix metalloproteinases: fold and function of their catalytic domains. Biochim Biophys Acta 1803:20\u201328. https:\/\/doi.org\/10.1016\/j.bbamcr.2009.04.003","journal-title":"Biochim Biophys Acta"},{"key":"987_CR116","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","volume":"365","author":"V Talman","year":"2016","unstructured":"Talman V, Ruskoaho H (2016) Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. Cell Tissue Res 365:563\u2013581. https:\/\/doi.org\/10.1007\/s00441-016-2431-9","journal-title":"Cell Tissue Res"},{"key":"987_CR117","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1161\/01.cir.99.21.2717","volume":"99","author":"M Terashima","year":"1999","unstructured":"Terashima M, Akita H, Kanazawa K, Inoue N, Yamada S, Ito K, Matsuda Y, Takai E, Iwai C, Kurogane H, Yoshida Y, Yokoyama M (1999) Stromelysin promoter 5A\/6A polymorphism is associated with acute myocardial infarction. Circulation 99:2717\u20132719. https:\/\/doi.org\/10.1161\/01.cir.99.21.2717","journal-title":"Circulation"},{"key":"987_CR118","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10557-005-5201-6","volume":"19","author":"A Tessone","year":"2005","unstructured":"Tessone A, Feinberg MS, Barbash IM, Reich R, Holbova R, Richmann M, Mardor Y, Leor J (2005) Effect of matrix metalloproteinase inhibition by doxycycline on myocardial healing and remodeling after myocardial infarction. Cardiovasc Drugs Ther 19:383\u2013390. https:\/\/doi.org\/10.1007\/s10557-005-5201-6","journal-title":"Cardiovasc Drugs Ther"},{"key":"987_CR119","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsd\u00f3ttir","year":"2013","unstructured":"Thorvaldsd\u00f3ttir H, Robinson JT, Mesirov JP (2013) Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 14:178\u2013192. https:\/\/doi.org\/10.1093\/bib\/bbs017","journal-title":"Brief Bioinform"},{"key":"987_CR120","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD (2018) Fourth universal definition of myocardial infarction. J Am Coll Cardiol 72:2231\u20132264. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.1038","journal-title":"J Am Coll Cardiol"},{"key":"987_CR121","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3109\/10799891003614808","volume":"30","author":"N Tyagi","year":"2010","unstructured":"Tyagi N, Vacek JC, Givvimani S, Sen U, Tyagi SC (2010) Cardiac specific deletion of N-methyl-d-aspartate receptor 1 ameliorates mtMMP-9 mediated autophagy\/mitophagy in hyperhomocysteinemia. J Recept Signal Transduct Res 30:78\u201387. https:\/\/doi.org\/10.3109\/10799891003614808","journal-title":"J Recept Signal Transduct Res"},{"key":"987_CR122","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/01.res.82.2.261","volume":"82","author":"JE Van Eyk","year":"1998","unstructured":"Van Eyk JE, Powers F, Law W, Larue C, Hodges RS, Solaro RJ (1998) Breakdown and release of myofilament proteins during ischemia and ischemia\/reperfusion in rat hearts: identification of degradation products and effects on the pCa-force relation. Circ Res 82:261\u2013271. https:\/\/doi.org\/10.1161\/01.res.82.2.261","journal-title":"Circ Res"},{"key":"987_CR123","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1073\/pnas.87.14.5578","volume":"87","author":"HE Van Wart","year":"1990","unstructured":"Van Wart HE, Birkedal-Hansen H (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A 87:5578\u20135582. https:\/\/doi.org\/10.1073\/pnas.87.14.5578","journal-title":"Proc Natl Acad Sci U S A"},{"key":"987_CR124","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nrd4390","volume":"13","author":"RE Vandenbroucke","year":"2014","unstructured":"Vandenbroucke RE, Libert C (2014) Is there new hope for therapeutic matrix metalloproteinase inhibition? Nat Rev Drug Discov 13:904\u2013927. https:\/\/doi.org\/10.1038\/nrd4390","journal-title":"Nat Rev Drug Discov"},{"key":"987_CR125","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cardfail.2010.09.017","volume":"17","author":"FM Velho","year":"2011","unstructured":"Velho FM, Cohen CR, Santos KG, Silvello D, Martinelli N, Biolo A, Clausell N, Rohde LE (2011) Polymorphisms of matrix metalloproteinases in systolic heart failure: role on disease susceptibility, phenotypic characteristics, and prognosis. J Card Fail 17:115\u2013121. https:\/\/doi.org\/10.1016\/j.cardfail.2010.09.017","journal-title":"J Card Fail"},{"key":"987_CR126","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/01.CIR.0000089090.05757.34","volume":"108","author":"FJ Villarreal","year":"2003","unstructured":"Villarreal FJ, Griffin M, Omens J, Dillmann W, Nguyen J, Covell J (2003) Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling. Circulation 108:1487\u20131492. https:\/\/doi.org\/10.1161\/01.CIR.0000089090.05757.34","journal-title":"Circulation"},{"key":"987_CR127","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.cardiores.2005.08.005","volume":"69","author":"LK von Wnuck","year":"2006","unstructured":"von Wnuck LK, Keul P, Lucke S, Heusch G, Wohlschlaeger J, Baba HA, Levkau B (2006) Degraded collagen induces calpain-mediated apoptosis and destruction of the X-chromosome-linked inhibitor of apoptosis (xIAP) in human vascular smooth muscle cells. Cardiovasc Res 69:697\u2013705. https:\/\/doi.org\/10.1016\/j.cardiores.2005.08.005","journal-title":"Cardiovasc Res"},{"key":"987_CR128","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/1358863x10394237","volume":"16","author":"F Wang","year":"2011","unstructured":"Wang F, Jin XP, Zhu M, Lin XF, Hu XF, Wang WF, Han Z, Huang LZ (2011) Genotype association of C(-735)T polymorphism of the MMP-2 gene with the risk of carotid atherosclerosis-vulnerable plaque in the Han Chinese population. Vasc Med 16:13\u201318. https:\/\/doi.org\/10.1177\/1358863x10394237","journal-title":"Vasc Med"},{"key":"987_CR129","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000008035","volume":"96","author":"J Wang","year":"2017","unstructured":"Wang J, Wei G, Hu W, Li L, Ye Y, Wang H, Wan W, Li R, Li L, Ma L, Meng Z (2017) Expression of matrix metalloproteinases-12 in ST-segment elevation myocardial infarction: a case\u2013control study. Medicine (Baltimore) 96:e8035. https:\/\/doi.org\/10.1097\/md.0000000000008035","journal-title":"Medicine (Baltimore)"},{"key":"987_CR130","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/1076029611412365","volume":"18","author":"L Wang","year":"2012","unstructured":"Wang L, Ma YT, Xie X, Yang YN, Fu ZY, Li XM, Liu F, Huang Y, Ma X, Chen BD, Yuan S, Sun MH, Peng X, Wang BZ (2012) Interaction between MMP-9 gene polymorphisms and smoking in relation to myocardial infarction in a Uighur population. Clin Appl Thromb Hemost 18:72\u201378. https:\/\/doi.org\/10.1177\/1076029611412365","journal-title":"Clin Appl Thromb Hemost"},{"key":"987_CR131","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1161\/01.cir.0000028818.33488.7b","volume":"106","author":"W Wang","year":"2002","unstructured":"Wang W, Schulze CJ, Suarez-Pinzon WL, Dyck JR, Sawicki G, Schulz R (2002) Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 106:1543\u20131549. https:\/\/doi.org\/10.1161\/01.cir.0000028818.33488.7b","journal-title":"Circulation"},{"key":"987_CR132","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1631\/jzus.B1300088","volume":"15","author":"X Wang","year":"2014","unstructured":"Wang X, Shi LZ (2014) Association of matrix metalloproteinase-9 C1562T polymorphism and coronary artery disease: a meta-analysis. J Zhejiang Univ Sci B 15:256\u2013263. https:\/\/doi.org\/10.1631\/jzus.B1300088","journal-title":"J Zhejiang Univ Sci B"},{"key":"987_CR133","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1161\/circulationaha.105.600353","volume":"114","author":"CS Webb","year":"2006","unstructured":"Webb CS, Bonnema DD, Ahmed SH, Leonardi AH, McClure CD, Clark LL, Stroud RE, Corn WC, Finklea L, Zile MR, Spinale FG (2006) Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling. Circulation 114:1020\u20131027. https:\/\/doi.org\/10.1161\/circulationaha.105.600353","journal-title":"Circulation"},{"key":"987_CR134","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1161\/CIRCULATIONAHA.111.035964","volume":"124","author":"D Westermann","year":"2011","unstructured":"Westermann D, Savvatis K, Lindner D, Zietsch C, Becher PM, Hammer E, Heimesaat MM, Bereswill S, Volker U, Escher F, Riad A, Plendl J, Klingel K, Poller W, Schultheiss HP, Tschope C (2011) Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy. Circulation 124:2082\u20132093. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.035964","journal-title":"Circulation"},{"key":"987_CR135","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1021\/cr9804543","volume":"99","author":"M Whittaker","year":"1999","unstructured":"Whittaker M, Floyd CD, Brown P, Gearing AJ (1999) Design and therapeutic application of matrix metalloproteinase inhibitors. Chem Rev 99:2735\u20132776. https:\/\/doi.org\/10.1021\/cr9804543","journal-title":"Chem Rev"},{"key":"987_CR136","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/cvr\/cvq042","volume":"87","author":"H Williams","year":"2010","unstructured":"Williams H, Johnson JL, Jackson CL, White SJ, George SJ (2010) MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis. Cardiovasc Res 87:137\u2013146. https:\/\/doi.org\/10.1093\/cvr\/cvq042","journal-title":"Cardiovasc Res"},{"key":"987_CR137","unstructured":"Wold Health Organization (2020) World health statistics 2020: monitoring health for the SDGs, sustainable development goals. In:World Health Organization"},{"key":"987_CR138","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/j.bbadis.2014.07.008","volume":"1842","author":"J Xu","year":"2014","unstructured":"Xu J, Shi GP (2014) Vascular wall extracellular matrix proteins and vascular diseases. Biochim Biophys Acta 1842:2106\u20132119. https:\/\/doi.org\/10.1016\/j.bbadis.2014.07.008","journal-title":"Biochim Biophys Acta"},{"key":"987_CR139","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1161\/01.CIR.0000091087.78630.79","volume":"108","author":"WM Yarbrough","year":"2003","unstructured":"Yarbrough WM, Mukherjee R, Escobar GP, Mingoia JT, Sample JA, Hendrick JW, Dowdy KB, McLean JE, Lowry AS, O\u2019Neill TP, Spinale FG (2003) Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling. Circulation 108:1753\u20131759. https:\/\/doi.org\/10.1161\/01.CIR.0000091087.78630.79","journal-title":"Circulation"},{"key":"987_CR140","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cardiores.2005.07.015","volume":"69","author":"S Ye","year":"2006","unstructured":"Ye S (2006) Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res 69:636\u2013645. https:\/\/doi.org\/10.1016\/j.cardiores.2005.07.015","journal-title":"Cardiovasc Res"},{"key":"987_CR141","doi-asserted-by":"publisher","first-page":"13055","DOI":"10.1074\/jbc.271.22.13055","volume":"271","author":"S Ye","year":"1996","unstructured":"Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM (1996) Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 271:13055\u201313060. https:\/\/doi.org\/10.1074\/jbc.271.22.13055","journal-title":"J Biol Chem"},{"key":"987_CR142","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/hrt.73.3.209","volume":"73","author":"S Ye","year":"1995","unstructured":"Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM (1995) Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J 73:209\u2013215. https:\/\/doi.org\/10.1136\/hrt.73.3.209","journal-title":"Br Heart J"},{"key":"987_CR143","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/s0945-053x(02)00053-7","volume":"21","author":"S Yoon","year":"2002","unstructured":"Yoon S, Kuivaniemi H, Gatalica Z, Olson JM, Buttice G, Ye S, Norris BA, Malcom GT, Strong JP, Tromp G (2002) MMP13 promoter polymorphism is associated with atherosclerosis in the abdominal aorta of young black males. Matrix Biol 21:487\u2013498. https:\/\/doi.org\/10.1016\/s0945-053x(02)00053-7","journal-title":"Matrix Biol"},{"key":"987_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.594226","volume":"8","author":"MT Zhao","year":"2020","unstructured":"Zhao MT, Ye S, Su J, Garg V (2020) Cardiomyocyte proliferation and maturation: two sides of the same coin for heart regeneration. Front Cell Dev Biol 8:594226. https:\/\/doi.org\/10.3389\/fcell.2020.594226","journal-title":"Front Cell Dev Biol"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-023-00987-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00395-023-00987-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-023-00987-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T09:05:41Z","timestamp":1702631141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00395-023-00987-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":144,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["987"],"URL":"https:\/\/doi.org\/10.1007\/s00395-023-00987-2","relation":{},"ISSN":["1435-1803"],"issn-type":[{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"assertion":[{"value":"10 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"18"}}